Monopar Therapeutics
Price & Volume
Stats
See moreOpen | $63.60 |
Previous Close | $63.29 |
Day Range | $61.10-$67.15 |
52W Range | $4.12-$68.18 |
Market Cap | $390.4M |
Shares Short | 136,401 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.84 |
News
See moreYahoo Finance • 9 days ago
Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting
Yahoo Finance • 20 days ago
Monopar a new outperform at Oppenheimer on Wilson disease candidate
Yahoo Finance • 2 months ago
Monopar therapeutics director Tsuchimoto sells $356k in stock
Yahoo Finance • 2 months ago
Monopar therapeutics director Starr sells $672k in stock
About
CEO | Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc |
CFO | Mr. Quan Anh Vu |
Address | 1000 Skokie Boulevard, Wilmette, IL, United States, 60091 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |
